These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 32027938)

  • 1. Advances and limitations of drug delivery systems formulated as eye drops.
    Jumelle C; Gholizadeh S; Annabi N; Dana R
    J Control Release; 2020 May; 321():1-22. PubMed ID: 32027938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases.
    Srinivasarao DA; Lohiya G; Katti DS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jul; 11(4):e1548. PubMed ID: 30506871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular disposition, pharmacokinetics, efficacy and safety of nanoparticle-formulated ophthalmic drugs.
    Bu HZ; Gukasyan HJ; Goulet L; Lou XJ; Xiang C; Koudriakova T
    Curr Drug Metab; 2007 Feb; 8(2):91-107. PubMed ID: 17305490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymer-based carriers for ophthalmic drug delivery.
    Imperiale JC; Acosta GB; Sosnik A
    J Control Release; 2018 Sep; 285():106-141. PubMed ID: 29964135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing lipid nanoparticles for topical ocular drug delivery.
    Alvarez-Trabado J; Diebold Y; Sanchez A
    Int J Pharm; 2017 Oct; 532(1):204-217. PubMed ID: 28893582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan Nanoparticles as a Mucoadhesive Drug Delivery System for Ocular Administration.
    Silva MM; Calado R; Marto J; Bettencourt A; Almeida AJ; Gonçalves LMD
    Mar Drugs; 2017 Dec; 15(12):. PubMed ID: 29194378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular delivery systems for topical application of anti-infective agents.
    Duxfield L; Sultana R; Wang R; Englebretsen V; Deo S; Rupenthal ID; Al-Kassas R
    Drug Dev Ind Pharm; 2016 Jan; 42(1):1-11. PubMed ID: 26325119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ophthalmic drug delivery systems--recent advances.
    Bourlais CL; Acar L; Zia H; Sado PA; Needham T; Leverge R
    Prog Retin Eye Res; 1998 Jan; 17(1):33-58. PubMed ID: 9537794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in Topical Ocular Drug Delivery.
    Yellepeddi VK; Palakurthi S
    J Ocul Pharmacol Ther; 2016 Mar; 32(2):67-82. PubMed ID: 26666398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time.
    Destruel PL; Zeng N; Seguin J; Douat S; Rosa F; Brignole-Baudouin F; Dufaÿ S; Dufaÿ-Wojcicki A; Maury M; Mignet N; Boudy V
    Int J Pharm; 2020 Jan; 574():118734. PubMed ID: 31705970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology for Topical Drug Delivery to the Anterior Segment of the Eye.
    Vaneev A; Tikhomirova V; Chesnokova N; Popova E; Beznos O; Kost O; Klyachko N
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactivation antioxidant and transglycating properties of N-acetylcarnosine autoinduction prodrug of a dipeptide L-carnosine in mucoadhesive drug delivery eye-drop formulation: powerful eye health application technique and therapeutic platform.
    Babizhayev MA
    Drug Test Anal; 2012 Jun; 4(6):468-85. PubMed ID: 21416634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in topical nano drug-delivery systems for the anterior ocular segment.
    Lakhani P; Patil A; Majumdar S
    Ther Deliv; 2018 Feb; 9(2):137-153. PubMed ID: 29325511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of thermosensitive in situ gels and drug-resin complex for ocular drug delivery: In vitro drug release and in vivo tissue distribution.
    Wei Y; Li C; Zhu Q; Zhang X; Guan J; Mao S
    Int J Pharm; 2020 Mar; 578():119184. PubMed ID: 32112932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticles for drug delivery to the anterior segment of the eye.
    Janagam DR; Wu L; Lowe TL
    Adv Drug Deliv Rev; 2017 Dec; 122():31-64. PubMed ID: 28392306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.
    Gause S; Hsu KH; Shafor C; Dixon P; Powell KC; Chauhan A
    Adv Colloid Interface Sci; 2016 Jul; 233():139-154. PubMed ID: 26318359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomicellar eye drops: a review of recent advances.
    Paganini V; Chetoni P; Di Gangi M; Monti D; Tampucci S; Burgalassi S
    Expert Opin Drug Deliv; 2024 Mar; 21(3):381-397. PubMed ID: 38396342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in Ocular Bioavailability and Prolonged Delivery of Tobramycin Sulfate Following Topical Ophthalmic Administration of Drug-Loaded Mucoadhesive Microparticles Incorporated in Thermosensitive In Situ Gel.
    Khan S; Warade S; Singhavi DJ
    J Ocul Pharmacol Ther; 2018 Apr; 34(3):287-297. PubMed ID: 29211593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled and continuous release ocular drug delivery systems: pros and cons.
    Abdelkader H; Alany RG
    Curr Drug Deliv; 2012 Jul; 9(4):421-30. PubMed ID: 22640036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.